ABL1 and Stroke: ATP5MG-related extensive functions were further confirmed using GAD DISEASE analysis (Figure 5F), in which, we achieved 34 functional disease annotations, including “type 2 diabetes” and “lymphoma, non-Hodgkin,” “diabetes mellitus, type 1,” “chronic obstructive pulmonary disease,” “acquired immunodeficiency syndrome,” “stroke, ischemic,” “leukemia, myelogenous, chronic, BCR-ABL-Positive,” “hepatitis B,” and “hepatitis C.”